Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0114 | 0.1323 | 0.0717 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase vps34-like | 0.0038 | 0.0056 | 0.0426 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0078 | 0.0727 | 0.5294 |
Loa Loa (eye worm) | hypothetical protein | 0.02 | 0.2759 | 0.8751 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0074 | 0.0652 | 0.1952 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0038 | 0.0056 | 0.0039 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0114 | 0.1323 | 0.411 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0427 | 0.1354 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0186 | 0.2526 | 0.2005 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0061 | 0.0437 | 0.3301 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0091 | 0.0934 | 0.6931 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0114 | 0.1323 | 1 |
Schistosoma mansoni | protein kinase | 0.0201 | 0.2769 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0091 | 0.0934 | 0.6931 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0114 | 0.1323 | 1 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0061 | 0.0437 | 0.3301 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0038 | 0.0056 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0074 | 0.0652 | 0.2069 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.0114 | 0.1323 | 0.0717 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0201 | 0.2769 | 0.2264 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0114 | 0.1323 | 1 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0114 | 0.1323 | 1 |
Schistosoma mansoni | protein kinase | 0.0201 | 0.2769 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.3152 | 1 |
Echinococcus granulosus | Receptor type tyrosine protein phosphatase O | 0.0582 | 0.9142 | 0.9082 |
Brugia malayi | Neuronal symmetry protein 1 | 0.0201 | 0.2769 | 0.8765 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0078 | 0.0727 | 0.5294 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0046 | 0.0145 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0114 | 0.1323 | 1 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0114 | 0.1323 | 0.4689 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0038 | 0.0056 | 0.0034 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0091 | 0.0934 | 0.2963 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0055 | 0.0336 | 0.1064 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0224 | 0.3152 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.004 | 0.009 | 0.0286 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0634 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0051 | 0.0264 | 0.1637 |
Loa Loa (eye worm) | STE/STE11/ASK protein kinase | 0.0061 | 0.0437 | 0.1385 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0114 | 0.1323 | 1 |
Giardia lamblia | Phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.0055 | 0.0338 | 0.5 |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.0111 | 0.1266 | 0.9555 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0186 | 0.2526 | 0.2005 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0055 | 0.0336 | 0.0933 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.0201 | 0.2769 | 0.2264 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.868 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.846 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.817 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.762 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.686 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.247 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.237 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.